发明名称 |
Treatment of vaginal atrophy in women with cardiovascular pathology risk |
摘要 |
The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology. |
申请公布号 |
US8835414(B2) |
申请公布日期 |
2014.09.16 |
申请号 |
US200913140602 |
申请日期 |
2009.08.07 |
申请人 |
ITF Research Pharma S.L.U. |
发明人 |
Fernández Álvaro Acebrón;Lousame Dolores Blanco;Del Prado Jaime Moscoso;Magro Concepción Nieto |
分类号 |
A61K31/56;A61K47/32;A61K31/566;A61K9/00 |
主分类号 |
A61K31/56 |
代理机构 |
Hoffmann & Baron, LLP |
代理人 |
Hoffmann & Baron, LLP |
主权项 |
1. A method of treatment of urogenital atrophy in woman comprising the vaginal administration of pharmaceutical estriol formulations with the capacity of self-limiting the absorption of estriol to a woman in need thereof, wherein said women suffer or have suffered a venous thromboembolic pathology, a coronary or cerebrovascular disease or migraine with aura and wherein the pharmaceutical formulation provides a dose of estriol less than or equal to 0.3 mg/day. |
地址 |
Alcobendas, Madrid unknown |